| |
| |
|
| Insider
Information: |
Hooper Suzanne Sawochka |
| Relationship: |
|
| City: |
Dublin 2 |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
39,738 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,342,171 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
39,738 |
|
|
| Total
Value |
$4,342,171 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Jazz Pharmaceuticals Inc |
JAZZ |
EVP & General Counsel |
2019-02-27 |
39,738 |
2012-08-09 |
0 |
Premium* |
|
|
Ngm Biopharmaceuticals Inc |
NGM |
|
2024-04-05 |
0 |
2019-04-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2015-08-10 |
4 |
D |
$181.48 |
$828,456 |
D/D |
(4,565) |
41,855 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2015-04-14 |
4 |
AS |
$181.45 |
$725,800 |
D/D |
(4,000) |
48,224 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2014-12-09 |
4 |
AS |
$178.79 |
$331,119 |
D/D |
(1,852) |
47,795 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2015-08-11 |
4 |
AS |
$177.82 |
$711,280 |
D/D |
(4,000) |
37,855 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2015-07-14 |
4 |
AS |
$177.79 |
$711,160 |
D/D |
(4,000) |
46,420 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2015-03-05 |
4 |
D |
$174.76 |
$364,724 |
D/D |
(2,087) |
52,224 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2015-05-12 |
4 |
AS |
$173.85 |
$695,400 |
D/D |
(4,000) |
46,297 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2014-11-11 |
4 |
AS |
$173.63 |
$321,563 |
D/D |
(1,852) |
48,249 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2015-06-09 |
4 |
AS |
$173.16 |
$692,640 |
D/D |
(4,000) |
46,420 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2015-03-10 |
4 |
AS |
$170.36 |
$315,336 |
D/D |
(1,851) |
52,224 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2015-02-27 |
4 |
D |
$170.09 |
$159,715 |
D/D |
(939) |
54,311 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2014-09-08 |
4 |
AS |
$168.00 |
$311,136 |
D/D |
(1,852) |
50,619 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2015-02-10 |
4 |
AS |
$166.90 |
$308,932 |
D/D |
(1,851) |
47,575 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2018-05-11 |
4 |
S |
$165.00 |
$1,237,500 |
D/D |
(7,500) |
30,747 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2015-01-13 |
4 |
AS |
$161.73 |
$299,362 |
D/D |
(1,851) |
47,575 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2017-04-27 |
4 |
AS |
$160.00 |
$400,000 |
D/D |
(2,500) |
39,649 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2017-05-09 |
4 |
AS |
$160.00 |
$400,000 |
D/D |
(2,500) |
37,149 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2017-06-23 |
4 |
AS |
$160.00 |
$67,200 |
D/D |
(420) |
36,902 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2017-07-20 |
4 |
AS |
$160.00 |
$732,800 |
D/D |
(4,580) |
32,322 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2014-03-05 |
4 |
D |
$157.60 |
$243,807 |
D/D |
(1,547) |
57,135 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2014-07-08 |
4 |
AS |
$155.00 |
$287,215 |
D/D |
(1,853) |
57,554 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2016-08-09 |
4 |
D |
$150.01 |
$684,796 |
D/D |
(4,565) |
36,699 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2014-08-15 |
4 |
AS |
$150.00 |
$100,050 |
D/D |
(667) |
51,804 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and General Counsel |
• – – |
2014-10-16 |
4 |
AS |
$150.00 |
$100,050 |
D/D |
(667) |
49,434 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2018-03-05 |
4 |
D |
$143.39 |
$177,660 |
D/D |
(1,239) |
38,247 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
